SCHEMBL6958219

SCHEMBL6958219

O=C(Cc1ccccc1)NCCc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.68
NPC1 O15118 1/20 0.68
RAB9A P51151 1/20 0.68
TAAR1 Q96RJ0 1/20 0.68
KMT2A Q03164 6/20 0.64
MEN1 O00255 5/20 0.64
MAPT P10636 4/20 0.64
ALDH1A1 P00352 4/20 0.64
LMNA P02545 1/20 0.64
MAOA P21397 1/20 0.64
MAOB P27338 1/20 0.64
HTT P42858 1/20 0.64
CA1 P00915 1/20 0.63
CA2 P00918 1/20 0.63
CA5A P35218 1/20 0.63
CA7 P43166 1/20 0.63
CA5B Q9Y2D0 1/20 0.63
GAA P10253 2/20 0.59
HPGD P15428 2/20 0.59
L3MBTL1 Q9Y468 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6961718 0.86 SMN1; SMN2 (0.68) SMN1; SMN2NPC1RAB9ATAAR1KMT2A
SCHEMBL6961756 0.85 KMT2A (0.67) SMN1; SMN2NPC1RAB9AKMT2AMEN1
SCHEMBL4153733 0.84 HPGD (0.79) SMN1; SMN2TAAR1KMT2AMEN1ALDH1A1
SCHEMBL10570417 0.84 ALDH1A1 (0.78) SMN1; SMN2RAB9AKMT2AMEN1MAPT
SCHEMBL8192655 0.84 KMT2A (0.66) SMN1; SMN2NPC1RAB9ATAAR1KMT2A
SCHEMBL7824219 0.82 ALDH1A1 (0.53) SMN1; SMN2KMT2AMEN1MAPTALDH1A1
SCHEMBL2510372 0.82 KMT2A (0.56) SMN1; SMN2KMT2AMEN1MAPTALDH1A1
SCHEMBL1395699 0.82 CNR1 (0.60) SMN1; SMN2NPC1RAB9ATAAR1KMT2A
SCHEMBL20718868 0.82 ALDH1A1 (0.60) SMN1; SMN2NPC1RAB9ATAAR1KMT2A
SCHEMBL17117203 0.82 NPC1 (0.67) SMN1; SMN2NPC1RAB9ATAAR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108727212-A A kind of synthesis of Mirabegron intermediate (R) -2- hydroxy-ns-(4- nitrophenethyls) -2- phenyl-acetamides 安徽德信佳生物医药有限公司 2018-11-02 CN disclosed
WO-2015044965-A1 A PROCESS FOR PREPARATION OF MIRABEGRON AND ALPHA CRYSTALLINE FORM THEREOF MEGAFINE PHARMA (P) LTD. (IN) 2015-04-02 WO disclosed
EP-0713483-B1 AMIDINE DERIVATIVES WITH NITRIC OXIDE SYNTHETASE ACTIVITIES ASTRAZENECA AB (SE) 2003-01-15 EP disclosed
US-6030985-A Amidine derivatives with nitric oxide synthetase activities ASTRA AKTIEBOLAG (SE) 2000-02-29 US disclosed
US-5807885-A Amidine derivatives with nitric oxide synthetase activities ASTRA AKTIEBOLAG (SE) 1998-09-15 US disclosed
WO-1995005363-A1 AMIDINE DERIVATIVES WITH NITRIC OXIDE SYNTHETASE ACTIVITIES ASTRA AKTIEBOLAG (SE) 1995-02-23 WO disclosed